Pulmonary Cell News Volume 10.38 | Oct 14 2021

    0
    49






    2021-10-14 | PULCN 13.38


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 10.38 – 14 October, 2021
    TOP STORY

    Signatures of Plasticity, Metastasis, and Immunosuppression in an Atlas of Human Small Cell Lung Cancer

    Scientists sequenced 155,098 transcriptomes from 21 human biospecimens, including 54,523 small cell lung cancer (SCLC) transcriptomes. They observed greater tumor diversity in SCLC than lung adenocarcinoma, driven by canonical, intermediate, and admixed subtypes.
    [Cancer Cell]

    AbstractGraphical Abstract

    Free Wallchart: Dynamic Modeling in Organoids
    PUBLICATIONSRanked by the impact factor of the journal

    TSSK4 Upregulation in Alveolar Epithelial Type-II Cells Facilitates Pulmonary Fibrosis through HSP90-AKT Signaling Restriction and AT-II Apoptosis

    Alveolar epithelial injury is one of the important pathological changes in idiopathic pulmonary interstitial fibrosis, but the regulatory mechanism remains unclear. The authors reported that alveolar epithelial type-II cells played important roles in the pathological process of pulmonary fibrosis.
    [Cell Death & Disease]

    Full Article

    In Vitro Impact Preliminary Assessment of Airborne Particulate from Metalworking and Woodworking Industries

    3D airway epithelial tissues allowed to mimic exposure conditions in vitro, generated human-relevant toxicology data, and allowed to elucidate the mode of action of pollutants.
    [Scientific Reports]

    Full Article

    In Vitro Genotoxicity of Dibutyl Phthalate on A549 Lung Cells at Air-Liquid Interface in Exposure Concentrations Relevant at Workplaces

    Investigators exposed A549 alveolar epithelial cells at the air-liquid interface to unravel the genotoxic and oxidative stress-inducing potential of dibutyl phthalate with concentrations relevant at occupational settings.
    [Environmental and Molecular Mutagenesis]

    Abstract

    CCCTC-Binding Factor Transcriptionally Regulates Galectin-7 and Activates the JNK/STAT3 Axis to Aggravate Bronchial Epithelial Cell Injury

    Human bronchial epithelial cells BEAS-2B were stimulated with transforming growth factor-β1 at a concentration of 10 ng/mL, and CCCTC-binding factor (CTCF) overexpression plasmid and CTCF small interfering RNA were transfected into the cells.
    [Pediatric Pulmonology]

    Abstract

    Evolution of MET and NRAS Gene Amplification as Acquired Resistance Mechanisms in EGFR Mutant NSCLC

    A patient-derived cell line obtained at the time of disease progression was used to identify NRAS gene amplification as an additional driver of drug resistance to combination EGFR/MET therapies.
    [npj Precision Oncology]

    Full Article

    An SETD1A/Wnt/β-Catenin Feedback Loop Promotes NSCLC Development

    Scientists found that SETD1A positively regulated the Wnt/β-catenin pathway via interacting with and stabilizing β-catenin.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Potentiated Lung Adenocarcinoma (LUAD) Cell Growth, Migration and Invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 Axis

    Cell functional experiments revealed that lncRNA DARS-AS1 participated in enhancing lung adenocarcinoma proliferation, invasion, and migration by inhibiting miR-188-5p.
    [Aging]

    Full Article

    Protein Co-Expression Network-Based Profiles Revealed from Laser-Microdissected Cancerous Cells of Lung Squamous-Cell Carcinomas

    Researchers unveiled disease-related protein networks by proteomic and bioinformatic assessment of laser-microdissected cancerous cells from seven lung squamous cell cancer compared with eight representative lung adenocarcinomas.
    [Scientific Reports]

    Full Article

    Watch this innovation showcase from ISSCR 2021 on applications of hPSC-derived lung models.
    REVIEWS

    Treating Disease Progression with Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: Novel Targeted Agents and Combination Strategies

    In this review, the post-osimertinib treatment options for EGFR-mutated non-small cell lung cancer are analyzed, with an outlook to ongoing clinical trials.
    [ESMO Open]

    Full Article

    INDUSTRY AND POLICY NEWS

    Algernon Pharmaceuticals Files US FDA Pre-IND Meeting Request for Ifenprodil Chronic Cough Phase II Study

    Algernon Pharmaceuticals, Inc. announced that it has filed a pre-IND meeting request with the US FDA for its investigation of NP-120 for a planned Phase II study for the treatment of refractory chronic cough.
    [Algernon Pharmaceuticals Inc.]

    Press Release

    FEATURED EVENT

    Biological Assemblies: Phase Transitions

    November 1 – 3, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Advanced Research Assistant – Human Cell Atlas

    Wellcome Sanger Institute – Cambridge, England, United Kingdom

    Postdoctoral Fellowship – Lung Cancer

    Massachusetts General Hospital – Boston, Massachusetts, United States

    Postdoctoral Research Fellow – Lung Injury

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    Postdoctoral Scholar – Immunology of Lungs

    The University of Tennessee Health Science Center – Memphis, Tennessee, United States

    Assistant/Associate/Full Professor Tenure-Track – Aging and Inflammation

    Medical College of Georgia, Augusta University – Augusta, Georgia, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter